Women with a double-negative cervical cancer screening test have a very low chance of developing intraepithelial neoplasia and cervical cancer. Cervical cancer screening includes cervical cytology and HPV screening, and women with a negative combined test have a very low chance of developing intraepithelial neoplasia and cervical cancer. Women are advised to undergo cervical cancer screening every 3 years. For patients with high-risk factors, the frequency of screening can be increased appropriately, and for older, low-risk people, the screening period can be extended appropriately. Patients with negative cervical cancer screening have a very low risk of cancer, but they are still at risk of cancer, and are advised to seek timely medical treatment if they develop relevant symptoms to avoid delaying their condition.